Liver Health is Public Health Resources

In response to the need, the Liver Health is Public Health initiative will elevate liver health to its rightful place on the global public health agenda. It will educate the public about liver health and disease prevention and will pave the way for best practices that account for differences in: stage of disease, patient preferences, values, culture, language, geography, and socioeconomic environment.

 
 
 

Liver Health Education, Support, and Tools

General Liver Disease Resources

Explore GLI's unique curated list of education, support, and tools for patients with liver disease and the people who support them.

  • Getting Access to New, Experimental Drugs
    Information for doctors and patients on obtaining access to medicines that are in development, are being tested in clinical trials, or are not yet approved by the FDA. 

  • Drug Cost Facts
    Your comprehensive guide to the drug cost ecosystem powered by Biotechnology Innovation Organization.

  • National Institute of Diabetes and Digestive and Kidney Diseases
    NIDDK conducts and supports research on many of the most common, costly, and chronic conditions to improve health.

  • World Health Organization
    Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people.

  • Lotsa Helping Hands
    Easily organize meals and help for friends & family in need.

  • Patient Advocate Foundation
    Patient Advocate Foundation (PAF) is a national 501 (c)(3) non-profit organization which provides case management services and financial aid to Americans with chronic, life threatening and debilitating illnesses.


Looking for more?

Become part of GLI's Advanced Advocacy Academy, meeting annually in Washington, D.C. or virtually.

Together, we can collaborate as a force that ensures that liver disease has its proper place on the global public health agenda.


Autoimmune

Primary Biliary Cholangitis

  • Living With PBC App
    Empowering you to take an active role in tracking and monitoring all aspects of your primary biliary cholangitis.

Primary Sclerosing Cholangitis

  • PSC Partners Seeking a Cure
    PSC Partners Seeking a Cure provides education and support to PSC patients, families and caregivers and raises funds to research causes, treatments and cures for primary sclerosing cholangitis.

Autoimmune Hepatitis

  • Autoimmune Hepatitis Association
    Provide support and hope to patients and families affected by autoimmune hepatitis through disease education and provision of research opportunities.

Back to top


Cancer

GLI’s Liver Cancer Lessons
GLI is proud to provide up to date and evidence based educational information about liver and bile duct cancers. Our information addresses topics important to anyone at risk for developing cancer in the liver and anyone who is living with the disease.

NCCN Guidelines for Patients: Liver Cancer
GLI is pleased to sponsor the NCCN Guidelines for Patients: “Liver Cancer”.

NCCN Guidelines for Patients: Gallbladder and Bile Duct Cancers 
GLI is proud to sponsor the NCCN Guidelines for Patients: “Gallbladder and Bile Duct Cancers”. 

  • GLI's Liver Cancer Glossary
    Terms and acronyms you need to know regarding liver cancer.

  • American Cancer Society
    If you have liver cancer or are close to someone who does, knowing what to expect can help you cope. Here you can find out all about liver cancer, including risk factors, symptoms, how it is found, and how it is treated.

  • Cancer Stories: The Art of Oncology
    This podcast channel features a dramatic reading of stories from terminally ill cancer patient and oncologists from  performed by a celebrity actor or artist, followed by a Q&A session with the author of the article, hosted by JCO consultant editor Lidia Schapira, MD, FASCO.

  • Smart Patients - Liver Cancer Community
    Join the Liver Cancer community to learn from other patients and caregivers affected by liver cancer.

  • Triage Cancer
    Triage Cancer is a national, nonprofit organization that provides education on the practical and legal issues that may impact individuals diagnosed with cancer and their caregivers, through events, materials, and resources.

  • Blue Faery: The Adrienne Wilson Liver Cancer Association
    Blue Faery's mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma, through research, education and advocacy.

  • Cholangiocarcinoma Foundation
    To find a cure and improve the quality of life for those affected by cholangiocarcinoma.

Back to top


NASH/NAFLD

Nonalcoholic Fatty Liver Disease (NAFLD) & Nonalcoholic Steatohepatitis (NASH)

Personalized Nutrition App
Eating for liver health is easy with the Global Liver Institute-NutriStyle Inc. personalized nutrition app.

After Your COVID-19 Vaccination, Take the Next Step for Your Liver Health [PDF]
GLI and Summit Clinical Research are promoting NASH disease awareness in the context of liver health and COVID-19 vaccination via partnerships with city vaccine centers and direct patient education. Contact NASH@globalliver.org for more information on this initiative and this resource.

U.S. NASH Action Plan [PDF]
GLI and the GLI NASH Council released the U.S. NASH Action Plan to comprehensively address NASH and its impact on patients and families, public health, and the economy.


U.S. NASH Action Plan 2021 Scorecard [PDF]
This year-end scorecard lists the accomplishments achieved according to the detailed agenda in the U.S. NASH Action Plan for each relevant stakeholder group — patients/carepartners, clinicians, medical societies, patient advocacy organizations, industry, payors, health systems, regulators, and policymakers. While gaps and challenges remain, tracking and acknowledging NASH successes according to the U.S. NASH Action Plan is pivotal for the field to respond on a national scale in 2022 and beyond.

The Language of NASH: A Narrative Guide to Communication on NASH [PDF]
To increase awareness of fatty liver disease, we all need to speak the same language. This framework for communication about NAFLD and NASH will help physicians, patients, caregivers, families, and advocates use the same wording to send a clear message: it’s time to increase awareness, diagnosis and treatment options for NASH.

NASH Core Curriculum: A Comprehensive Online Resource Center
GLI, in collaboration with Clinical Care Options, has launched an online resource center to improve clinician understanding of foundational concepts in NASH diagnosis, management, and emerging pharmacologic treatment strategies. The resources will be added throughout the first half of 2021 and are being developed primarily for clinicians, including advanced practice clinicians, in hepatology, gastroenterology, endocrinology, and primary care. The full curriculum will include CME/CE-certified video modules, ClinicalThought™ expert commentaries, and downloadable presentations and resources.

International NASH Day
Join us annually on the second Thursday of June to raise awareness about NASH. International NASH Day 2022 will be June 9.

 
 

NAFLD/NASH: Have You Been Diagnosed?
A guide for those living with a NASH or NAFLD diagnosis.

NAFLD/NASH: Am I at Risk?
Information about NASH and NAFLD, and tips for maintaining your liver health.

Pediatric NAFLD/NASH
NASH and NAFLD occur in children as well. Find out more about the signs, diagnosis, and treatment.

 

A Guide to Participating in Clinical Trials for Patients with NAFLD/NASH

Comprehensive answers to your questions about clinical trials for NAFLD/NASH patients and caregivers - What they are, why they are important, questions to ask, and where to find them.

 
  • NASH: Connecting the dots with patients in mind [PDF]
    “Connecting patients to their sense of self‐efficacy and their communities is essential to defeating NASH,” shares Donna Cryer, president and CEO of GLI. Read more about the connections that patients, primary care providers, specialists, policymakers, and advocacy organizations around the world can make to address the epidemic of nonalcoholic steatohepatitis in an October 2020 editorial by Cryer published in the journal, Endocrinology, Diabetes & Metabolism.

  • NAFLD & NASH in the Hispanic Population
    NAFLD and NASH have a greater prevalence in the Hispanic population. This infographic describes the genetic and environmental factors putting Hispanics in the U.S. at high risk for fatty liver disease.

  • Tandem Crises: Liver Disease and Opioids
    Due to the horrific toll it is taking on lives, communities and our healthcare system, the opioid crisis is a great and immediate healthcare emergency. This infographic describes the relationship between the abuse of opioid medications and liver disease.

  • The NASH Education Program - A GENFIT Initiative
    This program raises awareness around NASH and NAFLD by providing information and background on the many aspects of these conditions including disease state, prevalence, risk factors, diagnosis, and treatment.

  • Surfing the NASH Tsunami Podcast: Driving The Discussion In Fatty Liver Disease
    In this weekly podcast, drug developers, investors, researchers, and corporate executives wrestle to understand what is happening in the commercial development of NASH medications. Roger Green, MBA, hosts the podcast and GLI's Donna Cryer, JD, is frequently featured as a guest speaker.

Back to top


Transplant

  • United Network for Organ Sharing
    Our mission is to advance organ availability and transplantation to support patients through education, technology and policy development.

  • Organize
    ORGANIZE is a US-based non-profit focused on bringing reform to the organ donation system.

Back to top


Pediatric

  • Johns Hopkins Pediatric Liver Center
    The staff at the Pediatric Liver Center in the Division of Gastroenterology, Hepatology and Nutrition at the Johns Hopkins Children's Center is committed to offering a comprehensive and compassionate approach to the diagnosis and management of pediatric liver disease.

Back to top


Viral

Hepatitis C

  • National Alliance of State and Territorial AIDS Directors
    NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.

Back to top



This content is intended to provide helpful health information to the general public. This content is not intended as medical advice for individual problems. Global Liver Institute, including its board of directors and staff personnel, specifically disclaim all responsibility for any liability, loss, or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the GLI content.